Evidence map›Paper›PMID 39175765›Full record

ArticleFrontiers in neurology2024

Multiple sclerosis in

Adina Wise, Roberto A Ortega, Deborah Raymond, Alessandra Cervera, Emma Thorn, Katherine Leaver, David S Russell, Susan B Bressman, John F Crary, Rachel Saunders-Pullman

Abstract read
In one paragraph

Article in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Co-occurrence of parkinson disease and multiple sclerosis - a critical note.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adina WiseDepartment of Neurology, Mount Sinai Beth Israel Medical Center, New York, NY, United States.
Roberto A OrtegaDepartment of Neurology, Mount Sinai Beth Israel Medical Center, New York, NY, United States.
Deborah RaymondDepartment of Neurology, Mount Sinai Beth Israel Medical Center, New York, NY, United States.
Alessandra CerveraDepartments of Pathology, Neuroscience, and Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Emma ThornDepartments of Pathology, Neuroscience, and Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Katherine LeaverDepartment of Neurology, Mount Sinai Beth Israel Medical Center, New York, NY, United States.
David S RussellInstitute for Neurodegenerative Disorders, New Haven, CT, United States.
Susan B BressmanDepartment of Neurology, Mount Sinai Beth Israel Medical Center, New York, NY, United States.
John F CraryDepartments of Pathology, Neuroscience, and Artificial Intelligence & Human Health, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Rachel Saunders-PullmanDepartment of Neurology, Mount Sinai Beth Israel Medical Center, New York, NY, United States.

Funding

Research Education ComponentP30AG066514 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Margaret Sewell · 2020 to 2026
$31.0M
Clinical Pathological Study of Cognitive Impairment in Essential TremorR01NS086736 · NINDS · YALE UNIVERSITY · PI COSENTINO, STEPHANIE ANN, LOUIS, ELAN D · 2014 to 2023
$8.1M
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson DiseaseU01NS107016 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI OZELIUS, LAURIE J., SAUNDERS-PULLMAN, RACHEL · 2019 to 2023
$6.6M
Regulation of tau expression in Alzheimer disease and agingR01AG054008 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CRARY, JOHN FONDA · 2016 to 2020
$4.0M
Mechanisms of age-related tauopathyRF1NS095252 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CRARY, JOHN FONDA · 2022 to 2022
$2.5M
NIA NIH HHS P30 AG066514NIA NIH HHS R01 AG054008NINDS NIH HHS R01 NS086736NINDS NIH HHS RF1 NS095252NINDS NIH HHS U01 NS107016
6 · The paper itself

Abstract

Background: Methods: We investigated the co-occurrence of PD and MS in our research cohort and report on two cases of MS in Results: MS preceded PD in 1.4% (2/138) of participants with Discussion: The increased prevalence of MS in

Indexed as

autoimmune diseasesgeneticgenetic riskimmunology & inflammationLRRK2multiple sclerosisParkinson’s diseaseParkinson’s genes

Identifiers

PMID39175765
PMCPMC11340503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.